[EGFR and VEGF-targeted drugs: clinical evidence for their effects from evaluation of biomarkers].
Tamura
Kenji
K
D000906:Antibodies; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D015415:Biomarkers / Q000032:analysis*; D016503:Drug Delivery Systems / Q000379:methods*; D066246:ErbB Receptors / Q000276:immunology*; D019317:Evidence-Based Medicine; D006801:Humans; D042461:Vascular Endothelial Growth Factor A / Q000276:immunology*
D000906:Antibodies; D000970:Antineoplastic Agents; D015415:Biomarkers; D042461:Vascular Endothelial Growth Factor A; D066246:ErbB Receptors